Li, S., Wu, J., Huang, O., He, J., Zhu, L., Chen, W., . . . Shen, K. (2021). Clinical characteristics and disease outcomes in ER+ breast cancer: A comparison between HER2+ patients treated with trastuzumab and HER2- patients. BMC Cancer.
Styl ChicagoLi, Shuai, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, a Kunwei Shen. "Clinical Characteristics and Disease Outcomes in ER+ Breast Cancer: A Comparison between HER2+ Patients Treated With Trastuzumab and HER2- Patients." BMC Cancer 2021.
Citace podle MLALi, Shuai, et al. "Clinical Characteristics and Disease Outcomes in ER+ Breast Cancer: A Comparison between HER2+ Patients Treated With Trastuzumab and HER2- Patients." BMC Cancer 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..